2026-10-28Bullish
+8.78%24 hours changeQ3 adjusted EPS of $4.78 beat the $4.64 consensus and full-year EPS guidance rose to $18.30-$18.70.
read the report →Labcorp Holdings Inc. is a diagnostics and research company with two segments, Diagnostics Laboratories and Biopharma Laboratory Services. It offers routine blood and urine testing as well as specialty, gene-based and oncology-related testing.
Q3 adjusted EPS of $4.78 beat the $4.64 consensus and full-year EPS guidance rose to $18.30-$18.70.
read the report →